FDA Adverse Event Injury Summary report: N

OT ULTRALINK METER

MDR report key: 3203258 · Received July 2, 2013

Report

Report Number
3008382007-2013-18868
Event Type
Injury
Date Received
July 2, 2013
Date of Event
June 5, 2013
Report Date
June 6, 2013
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
PMA / PMN Number
K073231
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

THE LAY USER/PATIENT¿S PRODUCT(S) HAVE BEEN RETURNED AND EVALUATED BY LIFESCAN PRODUCT ANALYSIS ON (B)(4) 2013 WITH THE FOLLOWING FINDINGS: THE METER INVOLVED IN THIS CASE HAS PASSED ALL TESTING WITH NO FAULTS FOUND; THE COMPLAINT WAS NOT REPRODUCED. IF ANY ADDITIONAL INFORMATION IS AVAILABLE, THE FDA WILL BE NOTIFIED IN A FOLLOW UP REPORT. AT THIS TIME, WE CONSIDER THIS MATTER CLOSED.

Description of Event or Problem · 1

ON (B)(6) 2013 THE LAY USER/REPORTER, THE PATIENT¿S MOTHER, CONTACTED LIFESCAN TO REPORT THE ONE TOUCH ULTRALINK METER WAS GIVING INACCURATELY ERRATIC READINGS. THE SR. MEDICAL SURVEILLANCE SPECIALIST WAS ABLE TO CLASSIFY THE COMPLAINT BASED ON THE INFORMATION PROVIDED TO CUSTOMER SERVICE. ON (B)(6) 2013, THE PATIENT OBTAINED THE BLOOD GLUCOSE READINGS OF 428 MG/DL AND 178 MG/DL ON THE REPORTED METER OVER A TIME PERIOD GREATER THAN 20 MINUTES. THE PATIENT TOOK NO ACTIONS DUE TO THE METER READINGS. AT AN UNSPECIFIED TIME AFTERWARDS, THE PATIENT EXPERIENCED THE SYMPTOM OF SHAKING AND TESTED POSITIVE FOR LARGE AMOUNTS OF KETONES. THE PATIENT DID NOT SEEK ANY MEDICAL ATTENTION OR TREATMENT. THE PATIENT MANAGES HER DIABETES WITH INSULIN PUMP THERAPY. THE METER, TEST STRIPS AND CONTROL SOLUTION WERE REPLACED. THE PATIENT ALLEGEDLY SUFFERED SYMPTOMS SUGGESTING SEVERE HYPOGLYCEMIA AFTER OBTAINING ELEVATED METER READINGS. THEREFORE THIS COMPLAINT IS BEING REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
302357 OT ULTRALINK METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 3361723

Patients

Seq Age Sex Outcome Treatment
1 13 YR Life Threatening